Home
Conditions
Leukemia, Lymphoid

Clinical trial condition

Leukemia, Lymphoid

Explore clinical trials studying Leukemia, Lymphoid. Study availability and eligibility vary by location and protocol.

3,018 public trials 549 recruiting studies

Refine in advanced search Browse all conditions

Leukemia, Lymphoid trial results

Completed

A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

NCT01466153

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia (CLL), Disease Attributes, +17 more
Locations: Research Site Birmingham, Alabama, United States

Research Site Burbank, California, United States

Research Site La Jolla, California, United States

Research Site Palm Springs, California, United States

View all 54 locations

View Trial Details

Completed

A Phase I/II, a Single Arm, Open-label Study of Ofatumumab (GSK1841157) in Patients With Previously Treated Chronic Lymphocytic Leukemia

NCT01077622

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: GSK Investigational Site Aichi, Japan

GSK Investigational Site Kanagawa, Japan

GSK Investigational Site Nagasaki, Japan

GSK Investigational Site Tokyo, Japan

View Trial Details

Completed

Healing Touch in Treating Patients Receiving Chemotherapy for Acute Myeloid Leukemia or Acute Lymphocytic Leukemia

NCT00321880

Conditions: Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Fatigue, +16 more
Locations: Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States

View Trial Details

Completed

Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease

NCT00448201

Conditions: Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +66 more
Locations: Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States

View Trial Details

Completed

Music in Reducing Anxiety and Pain in Adult Patients Undergoing Bone Marrow Biopsy for Hematologic Cancers or Other Diseases

NCT00376922

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +101 more
Locations: Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States

View Trial Details

Completed

Learning Impairments Among Survivors of Childhood Cancer

NCT00576472

Conditions: Acute Lymphoblastic Leukemia, Brain Diseases, Brain Neoplasms, +17 more
Locations: Duke University Medical Center Durham, North Carolina, United States

Medical University of South Carolina Charleston, South Carolina, United States

St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Completed

Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer

NCT00118352

Conditions: Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, +135 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

University of Torino Torino, Italy

View Trial Details

Completed

Laboratory Assay in Determining Cancer Resistance in Patients With Metastatic Cancer and in Healthy Participants

NCT00899496

Conditions: Adenocarcinoma, Adnexal Diseases, Blood Protein Disorders, +122 more
Locations: Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States

View Trial Details

Completed

Vorinostat, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Lymphoma or Previously Untreated T-Cell Non-Hodgkin Lymphoma or Mantle Cell Lymphoma

NCT00601718

Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +83 more
Locations: Puget Sound Oncology Consortium Seattle, Washington, United States

View Trial Details

Completed

Rasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer or Other Disease Undergoing Donor Stem Cell Transplant

NCT00513474

Conditions: Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +72 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Leukemia, Lymphoid

Leukemia, Lymphoid trial results

Related conditions